PHARMACARE Stock Overview
Dar Al-Shifa Pharmaceuticals Company manufactures, markets, and distributes medicines and chemicals in West Bank and Gaza Strip. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 4/6 |
| Dividends | 2/6 |
My Notes
Capture your thoughts, links and company narrative
Dar Al-Shifa Pharmaceuticals Company Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$3.35 |
| 52 Week High | US$3.35 |
| 52 Week Low | US$2.97 |
| Beta | -0.013 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | 6.31% |
| 3 Year Change | 0.24% |
| 5 Year Change | -6.44% |
| Change since IPO | -22.04% |
Recent News & Updates
Recent updates
Shareholder Returns
| PHARMACARE | PS Pharmaceuticals | PS Market | |
|---|---|---|---|
| 7D | 0% | -0.8% | 2.4% |
| 1Y | 6.3% | 9.2% | -13.6% |
Return vs Industry: PHARMACARE exceeded the PS Pharmaceuticals industry which returned 0.7% over the past year.
Return vs Market: PHARMACARE exceeded the PS Market which returned -8.9% over the past year.
Price Volatility
| PHARMACARE volatility | |
|---|---|
| PHARMACARE Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 6.2% |
| Market Average Movement | 2.9% |
| 10% most volatile stocks in PS Market | 4.1% |
| 10% least volatile stocks in PS Market | 1.7% |
Stable Share Price: PHARMACARE has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine PHARMACARE's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1986 | 423 | Bassim Subhi Farah Nasr | n/a |
Dar Al-Shifa Pharmaceuticals Company manufactures, markets, and distributes medicines and chemicals in West Bank and Gaza Strip. The company offers various human medicines, such as pills, capsules, creams, and liquids, as well as veterinary treatment products. Dar Al-Shifa Pharmaceuticals Company was founded in 1986 and is headquartered in Ramallah, the Palestinian Authority.
Dar Al-Shifa Pharmaceuticals Company Fundamentals Summary
| PHARMACARE fundamental statistics | |
|---|---|
| Market cap | US$30.15m |
| Earnings (TTM) | US$4.87m |
| Revenue (TTM) | US$30.71m |
6.2x
P/E Ratio1.0x
P/S RatioIs PHARMACARE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PHARMACARE income statement (TTM) | |
|---|---|
| Revenue | US$30.71m |
| Cost of Revenue | US$17.62m |
| Gross Profit | US$13.09m |
| Other Expenses | US$8.23m |
| Earnings | US$4.87m |
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.54 |
| Gross Margin | 42.63% |
| Net Profit Margin | 15.85% |
| Debt/Equity Ratio | 74.0% |
How did PHARMACARE perform over the long term?
See historical performance and comparisonDividends
2.9%
Current Dividend Yield18%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/03/18 06:42 |
| End of Day Share Price | 2022/12/19 00:00 |
| Earnings | 2021/12/31 |
| Annual Earnings | 2021/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Dar Al-Shifa Pharmaceuticals Company is covered by 0 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|